Synairgen Share News (SNG)

PR specialist Freshwater cut the dividend as profits fell to £32,000 from £106,000 in the six months to end February. Revenues fell to £3.66m from £4.51m."While the economic environment remains challenging, Freshwater is seeing greater stability and growth potential in most of its markets. Alongside this, the measures we have taken to cut costs have restored EBITDA operating margins to double-digit percentages in the second quarter and this is continuing in the third quarter," it said.Star Aim-listed oil explorer Cove Energy posted a loss of $1.65m, up from $546,000, as it funded its so far very successful drilling programme. Going forward, Cove says that following the success at Windjammer, the offshore partners requested the Mozambique authorities to change the drilling commitment to 6 deepwater wells. This request has been granted. Drilling of these 6 deepwater wells will continue in 2010 through to 2011 and will be followed by an appraisal programme. In Tanzania, it is working with its partners to commercialise the full gas production potential of the Mnazi Bay gas fields. Drug developer Synairgen says data from SNG001, its inhaled interferon beta product, in a new model of influenza shows for the first time that it can prevent the spread of infection from cell to cell, even after an influenza infection has taken hold. "This is potentially an important breakthrough in the treatment of flu virus infection rather than its prevention. This represents an exciting new development opportunity for our inhaled interferon beta product that extends beyond the existing opportunities identified for asthma and COPD," chief executive Richard Marsden added.Publisher Wilmington has decided the time is now right to invest in overseas expansion in the banking and finance sector and in deeper content and enhanced technology. It expects to invest up to £2m over the next 12 months and to see returns in the financial year ending June 2012 and beyond. Since February, "the trading performance of the group has been in line with our expectations," it said, with trading still very tough in the legal business.